Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand

• Main Authors: Unchalee Permsuwan, Sumitra Thongprasert, Buntitabhon Sirichanchuen
• Format: Journal
• Published: 2020
• Subjects: Economics, Econometrics and Finance; Medicine; Pharmacology, Toxicology and Pharmaceutics
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073458329&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/68362
• Institution: Chiang Mai University

© 2019 ISPOR–The professional society for health economics and outcomes research Objective: To assess the cost-effectiveness of first-line chemotherapy regimens for non-small cell lung cancer patients in Thailand. Methods: A Markov model comprising 3 health states (progression-free survival, progres...